34 results  1 of 2 

1 Luteolin inhibits H2O2-induced cellular senescence via modulation of SIRT1 and p53
Ri Zhe Zhu, Bing Si Li, Shang Shang Gao, Jae Ho Seo, Byung-Min Choi
Korean J Physiol Pharmacol.2021;25(4):297-305.   Published online 2021 July 1     DOI: http://dx.doi.org/10.4196/kjpp.2021.25.4.297
      
2 Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma
Miao Xue, Yanqin Wu, Wenzhe Fan, Jian Guo, Jialiang Wei, Hongyu Wang, Jizhou Tan, Yu Wang, Wang Yao, Yue Zhao, Jiaping Li
Cancer Res Treat.2020;52(3):925-937.   Published online 2020 March 30     DOI: http://dx.doi.org/10.4143/crt.2019.533
      
3 Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT
Sundong Lin, Lechu Yu, Yongqing Ni, Lulu He, Xiaolu Weng, Xuemian Lu, Chi Zhang
Diabetes Metab J.2020;44(1):158-172.   Published online 2019 October 28     DOI: http://dx.doi.org/10.4093/dmj.2018.0235
      
4 Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women
Tsutomu Ida, Hiroyuki Fujiwara, Takahiro Kiriu, Yoshimi Taniguchi, Akira Kohyama
J Gynecol Oncol.2019;30(6):e96.  Published online 2019 June 3     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e96
      
5 Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
Yong-Man Kim, Shin-Wha Lee, Young-Jae Lee, Ha-Young Lee, Jong-Eun Lee, Eun-Kyung Choi
J Gynecol Oncol.2019;30(3):e32.  Published online 2018 November 23     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e32
      
6 Retention Esophagitis as a Significant Clinical Predictor of Progression to Esophageal Cancer in Achalasia
Haewon Kim, Hyojin Park, HeeSeung Choi, Yooju Shin, Hyunsung Park, Young Hoon Youn, Jie-Hyun Kim
Clin Endosc.2018;51(2):161-166.   Published online 2018 March 6     DOI: http://dx.doi.org/10.5946/ce.2017.087
      
7 Clinical Characteristics and Prognosis of Differentiated Thyroid Carcinoma with Small Foci of Anaplastic Transformation
Hwa Young Ahn, Kyeong Choen Jung, Do Joon Park, Young Joo Park, Bo Youn Cho
Int J Thyroidol.2017;10(2):96-101.   Published online 2017 November 29     DOI: http://dx.doi.org/10.11106/ijt.2017.10.2.96
      
8 Basaloid Squamous Cell Carcinoma of the Head and Neck: Subclassification into Basal, Ductal, and Mixed Subtypes Based on Comparison of Clinico-pathologic Features and Expression of p53, Cyclin D1, Epidermal Growth Factor Receptor, p16, and Human Papillomavirus
Kyung-Ja Cho, Se Un Jeong, Sung Bae Kim, Sang-wook Lee, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim
J Pathol Transl Med.2017;51(4):374-380.   Published online 2017 June 8     DOI: http://dx.doi.org/10.4132/jptm.2017.03.03
      
9 Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer
Dong Won Baek, Byung Woog Kang, Soyoon Hwang, Jong Gwang Kim, An Na Seo, Han Ik Bae, Oh Kyoung Kwon, Seung Soo Lee, Ho Young Chung, Wansik Yu
Chonnam Med J.2017;53(2):140-146.   Published online 2017 May 25     DOI: http://dx.doi.org/10.4068/cmj.2017.53.2.140
      
10 Inhibition of Nicotinamide Phosphoribosyltransferase Induces Apoptosis in Estrogen Receptor-Positive MCF-7 Breast Cancer Cells
Mohammad Alaee, Shahnaz Khaghani, Kiarash Behroozfar, Zahra Hesari, Seyedeh Sara Ghorbanhosseini, Mitra Nourbakhsh
J Breast Cancer.2017;20(1):20-26.   Published online 2017 March 24     DOI: http://dx.doi.org/10.4048/jbc.2017.20.1.20
      
11 The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
Jee Soon Kim, Youn Soo Lee, Min Jung Jung, Yong Kil Hong
J Pathol Transl Med.2016;50(6):419-425.   Published online 2016 October 6     DOI: http://dx.doi.org/10.4132/jptm.2016.06.30
      
12 Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
Ji-Yeon Kim, Kyunghee Park, Hae Hyun Jung, Eunjin Lee, Eun Yoon Cho, Kwang Hee Lee, Soo Youn Bae, Se Kyung Lee, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Cancer Res Treat.2016;48(4):1338-1350.   Published online 2016 February 18     DOI: http://dx.doi.org/10.4143/crt.2015.430
      
13 Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
Taeryung Kim, Wonshik Han, Min Kyoon Kim, Jun Woo Lee, Jisun Kim, Soo Kyung Ahn, Han-Byoel Lee, Hyeong-Gon Moon, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, Seock-Ah Im, In Ae Park, Ju-Yeon Kim, Dong-Young Noh
J Breast Cancer.2015;18(1):16-21.   Published online 2015 March 27     DOI: http://dx.doi.org/10.4048/jbc.2015.18.1.16
      
14 Ki-67 and p53 expression as a predictive marker for early postoperative recurrence in pancreatic head cancer
Hohyun Kim, Chan Yong Park, Jae Hyuk Lee, Jung Chul Kim, Chol-Kyoon Cho, Hee Jun Kim
Ann Surg Treat Res.2015;88(4):200-207.   Published online 2015 March 26     DOI: http://dx.doi.org/10.4174/astr.2015.88.4.200
      
15 Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA Mutation
Rishi Agarwal, Kimberly Koenig, Eric Rohren, Vivek Subbiah
J Breast Cancer.2014;17(3):287-290.   Published online 2014 September 30     DOI: http://dx.doi.org/10.4048/jbc.2014.17.3.287
      
16 p53 Expression in a Malignant Mesothelioma Patient during Seven-Year Follow-up
So-My Koo, Soo-taek Uh, Dong Won Kim, Ki-Up Kim, Yang-Ki Kim
Tuberc Respir Dis.2014;76(6):284-288.   Published online 2014 June 28     DOI: http://dx.doi.org/10.4046/trd.2014.76.6.284
      
17 Effect Modification of Hormonal Therapy by p53 Status in Invasive Breast Cancer
Sei Hyun Ahn, Hwa Jung Kim, Wonshik Han, Jihyoung Cho, Gyungyub Gong, Kyung Hae Jung, Sung-Bae Kim, Byung Ho Son, Jong Won Lee
J Breast Cancer.2013;16(4):386-394.   Published online 2013 December 31     DOI: http://dx.doi.org/10.4048/jbc.2013.16.4.386
      
18 The Blocking of c-Met Signaling Induces Apoptosis through the Increase of p53 Protein in Lung Cancer
Hae-Yun Jung, Hyun-Jung Joo, Jong Kuk Park, Yeul Hong Kim
Cancer Res Treat.2012;44(4):251-261.   Published online 2012 December 31     DOI: http://dx.doi.org/10.4143/crt.2012.44.4.251
      
19 Association of p53 Expression with Metabolic Features of Stage I Non-Small Cell Lung Cancer
Shin Myung Kang, Won-Jung Koh, Gee Young Suh, Man Pyo Chung, Joungho Han, Hojoong Kim, O Jung Kwon, Sang-Won Um
Tuberc Respir Dis.2011;71(6):417-424.   Published online 2011 December 29     DOI: http://dx.doi.org/10.4046/trd.2011.71.6.417
      
20 Diagnostic p53 expression in gastric endoscopic mucosal resection
Jeong Hee Cho, Im Hwan Roe, Young Joo Jin
J Korean Med Sci.1999;14(4):412-416.   Published online 2009 June 19     DOI: http://dx.doi.org/10.3346/jkms.1999.14.4.412
      

 1 of 2